Medimetriks Pharmaceuticals, Inc. Receives FDA Approval for Xepi (ozenoxacin) Cream, 1%, a Novel Topical Antibiotic for Impetigo

FDA News, New FDA Approvals
December 14, 2017
A+ A-
Email Print

Article Link: Medimetriks Pharmaceuticals, Inc. Receives FDA Approval for Xepi (ozenoxacin) Cream, 1%, a Novel Topical Antibiotic for Impetigo

FAIRFIELD, N.J., Dec. 14, 2017 /PRNewswire/ — Medimetriks Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved Xepi (ozenoxacin) Cream, 1%, a new chemical entity for the treatment of impetigo in patients…

Source: FDA New Drug Approvals

Posted by

Newer Post
Older Post